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Abstract
Background: Actual differences of long term outcome of extrahepatic cholangiocarcinoma according to the
location of the tumor have not yet been studied. The aim of this study was to evaluate the prognosis and optimal
surgical procedure for middle (BD) cancer.
Methods: Among 109 patients with carcinoma of the extrahepatic BD underwent surgical resection, curative
resection of extrahepatic BD cancer was performed in 90 patients. They were classified into three groups according
to the location of tumors: DISTAL (n = 32), tumor was confined to the intrapancreatic bile duct; MID (n = 20), tumor
was located between below the confluence of the hepatic duct bifurcation and suprapancreatic portion of the BD;
and DIFFUSE (n = 38), tumor was located diffusely.
Results: Tumor involving the middle BD (MID or DIFFUSE) had a higher rate of perineural invasion as compared to
the DISTAL group. The overall and disease-free survival rate for the MID or DIFFUSE group was significantly worse
than that of DISTAL. In the MID/DIFFUSE group, there was no significant difference of survival according to the type
of the operation (pancreaticoduodenectomy or segmental BD resection). The multivariate analysis showed that
tumor involving middle BD (MID or DIFFUSE group) and node metastasis were independently poor prognostic
factors for the disease free and overall survival.
Conclusion: Extrahepatic cholangiocarcinoma involving the extrapancreatic BD has a worse prognosis than
those confined to the intrapancreatic BD. In patients with tumors confined to the middle BD, BD resection
can be considered as an alternative surgical procedure to pancreaticoduodenectomy, if an R0 resection can
be accomplished.
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Background
Extrahepatic cholangiocarcionoma is classified into peri-
hilar cholangiocarcinoma and distal bile duct (BD) can-
cer according to the anatomical location of the tumor as
defined in the 7th edition of American Joint Committee
on Cancer’s (AJCC) classification [1, 2]. For convenience,
distal BD cancer has been further subdivided into middle
BD carcinoma, which is defined as the infrahilar/
suprapancreatic area (or from the confluence of cystic
duct to the superior border of pancreas) and distal BD
cancer, which is referred to as intrapancreatic BD [3–6].
However, an exact location of the middle BD is difficult
to define because of different locations of the cystic duct
confluence. Additionally, tumors are rarely confined to
one segment (proximal, middle, or distal BD) microscop-
ically, and bile duct cancer tends to spread along the bile
duct epithelium longitudinally, rather be than confined
to one area [2, 7, 8]. While there are different operative
approaches between hilar cholangiocarcionma and extra-
hepatic bile duct cancer, pancreaticodudenectomy (PD)
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has been regarded as a standard operative procedure for
mid and distal BD cancer, although segmental BD resec-
tion can be applied in limited patients. For these rea-
sons, in recent literature, middle and distal BD cancer
were classified together as ‘distal bile duct’ cancer and
have a same AJCC 7th classification.
However, middle BD cancer has a different behavior
when compared to distal BD cancer. In cancer confined
to the intrapancreatic portion, periampullary structures,
such as the pancreas or duodenum, may limit the tumor
spread into adjacent tissues. In contrast, cancer located
in the middle BD may have a higher possibility of earlier
microscopic tumor invasion of the periductal structure
in the hepatodudenal ligament. This may affect the en-
casement of the adjacent hepatic artery or portal vein
earlier, and result in a higher chance of radial margin in-
volvement. However, although the possibility of poor
outcomes in middle CBD cancer have been suggested,
actual differences of long term outcome according to the
location have not yet been studied [5, 9–13] and the
study which showed prognostic impact of the primary
tumor site is rare [14]. Furthermore, the appropriate op-
erative procedure for tumors confined to the middle BD
has not been fully defined. Although usually, PD is
needed for curative resection in mid BD cancer, there
has been debate about whether segmental resection of
the bile duct can be an alternative treatment or not
when negative margins can be obtained [15].
Our hypothesis was that BD cancer involving the mid-
dle BD, may show a worse prognosis than cancer con-
fined to the intrapancreatic BD. For the treatment of
cancer confined to the mid BD, the type of surgical pro-
cedure (PD or segmental resection of BD) may not affect
the survival because tumor location in the mid BD may
be significantly poor prognostic factor regardless of op-
erative type. If this is true, segmental resection of the BD
in tumors confined to the mid BD would be justified.
Therefore, the aim of this study was to analyze the clini-
copathological factors that influence the survival of ex-
trahepatic BD cancer according to the location of the
tumor, and to determine the oncologic safety of segmen-
tal BD resection as an optimal surgical procedure for a
cancer confined to the middle BD.
Method
Population and study design
From March 2000 to August 2012, 110 patients with
adenocarcinoma of the distal BD underwent surgical re-
section at the Keimyung University Dongsan Medical
Center. Eighteen of the patients were unable to undergo
curative R0 resection; they either underwent an R1 or
R2 resection or had distant metastases. These patients
and additional two patients with in-hospital mortality
were excluded. The remaining 90 patients who had
extrahepatic cholangiocarcinoma originating from the
middle or distal bile duct histologically confirmed
with negative longitudinal or radial margin (R0) were
enrolled in this study. The 90 patients were classi-
fied into three groups according to the anatomical
location of the tumor based on histopathological
findings: 1) the distal BD cancer group (DISTAL
group), tumor was confined to the intrapancreatic
BD 2) the middle BD cancer group (MID group),
tumor was located between the confluence of the
hepatic duct bifurcation and suprapancreatic portion
of BD; and 3) the diffuse BD cancer group (DIFFUSE
group), tumor was located diffusely within the mid-
dle and intrapancreatic BD (Fig. 1). When the main
tumor was located in the intrapancreatic portion of
the BD, if tumor cells were present at the mid bile
duct in microscopic examination, the lesion was
classified as DIFFUSE group. Patients’ demographics,
perioperative outcomes, tumor histopathology, and
follow-up data were analyzed retrospectively based
on a prospectively recorded database. This retro-
spective study protocol was reviewed and approved
by the institutional review board of the Keimyung
University Dongsan Medical Center (11–308). The
consents from patients for this retrospective study
were waived by the institutional review board.
Fig. 1 Classification into the three groups according to anatomical
location of the tumor based on histopathological findings; the
DISTAL group (a), tumors confined to the intrapancreatic BD; the
MID group (b), tumors confined to the middle bile duct; and the
DIFFUSE group (c), tumors located in the diffusely middle and
intrapancreatic BD
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Preoperative management, surgical procedure and
histopathological evaluation
There were no absolute criteria for performing pre-
operative biliary drainage. In general, if patients showed
jaundice with bilirubin levels higher than 10 mg/dl or if
a biopsy was necessary, biliary drainage endoscopically
or percutaneously was performed.
The surgical procedure was determined by the extent
of the lesion. All patients in the DISTAL and DIFFUSE
groups underwent a standard PD or pylorus-preserving
pancreaticoduodenectomy (PPPD). In the MID group, a
segmental BD resection with hepaticojejunostomy was
performed when a negative margin could be obtained,
and PD was performed when obtaining of negative mar-
gin was not assured preoperatively or intraoperatively. A
routine resection of the lymph nodes around the porta
hepatis (No.12), retropancreatic (No.13), common hep-
atic artery and celiac trunk (No 8,9) was done.
During the study period, one pathologist reviewed the
pathology to verify whether each sample was feasible for
this study on the basis of the histopathologic diagnoses
recorded and accumulated. Tumor stages were classified
according to the 7th edition of AJCC. Postoperative sur-
gical complications were graded as described by the pro-
posed Dindo-Clavien classification system [16].
Follow up and diagnosis of recurrence
The routine follow-up program consisted of a physical
examination, computed tomography, and tumor markers
(carcinoembryonic antigen (CEA), carbohydrate antigen
(CA) 19–9) every 3 mohths for the first year, then every
6 months for the next 4 years, and thereafter, annually.
Statistical analysis
A statistical analysis were performed using SPSS, version
13.0 for Windows (SPSS,Inc., Chicago IL,USA). Com-
parison between the groups was performed using an
independent t test and ANOVA for continuous vari-
ables and Chi-square test for categorical variables.
Overall and disease-free survivals were calculated
using the Kaplan-Meier method. A univariate analysis
of the survival curves was performed using the log-rank
test. A multivariate regression analysis was performed
using a Cox proportional hazards model to identify the in-
dependent prognostic factors for survival. A P value of
<0.05 was considered statistically significant.
Results
Demographic, perioperative and histopahological results
The patient population consisted of 38 women and 52
men, with a mean age of 65 years (range, 33–83 years).
These patients were grouped as follows: 32 patients of
the DISTAL group (35.6 %), 20 of the MID group
(22.2 %) and 38 of the DIFFUSE (42.2 %). In the MID
group, five patients (25.0 %) underwent PPPD, and the
remaining 15 patients underwent BD resection. The
demographic factors, perioperative results, and histo-
pathological results showed no differences between three
groups. However, a higher rate of T3 was observed in
the DISTAL and DIFFUSE groups than the MID group.
In the DISTAL group, rate of perineural invasion was
lower than that of the MID and DIFFUSE groups
(Table 1).
Survival analysis according to the location, distal vs. mid
vs. diffuse, of the tumor
During the mean follow-up period of 38.8 ± 30.0 (range:
4.5–163.0) months, the 3- and 5- year overall survival
rates for the 90 patients were 55.6 and 43.6 %, re-
spectively. The 3- and 5-year disease-free survival
rates were 41.6 and 29.9 %, respectively. The overall
and disease-free survival rate for the DISTAL group
was significant higher than that of the MID and DIF-
FUSE groups (P = 0.010 and 0.001, respectively. Fig. 2).
The pattern of recurrence was not different among
the 3 groups (Table 1).
Further survival analysis, according to the stage
and presence of perineural invasion, was done among
the three groups. While there was no significant sur-
vival difference among the three groups in N1 pa-
tients (P = 0.202), in N0 patients (including stage IIa
(T3N0)), patients of the DISTAL group showed a sig-
nificantly better survival rate than that of the MID
and DIFFUSE group. (P = 0.010, Fig. 3) There was no
significant survival difference between the DISTAL
and MID/DIFFUSE groups depending on the pres-
ence of perineural invasion (Fig. 4).
Survival difference according to the type of resection,
segmental resection vs. PD, of the middle bile duc
carcinomat
In the MID/DIFFUSE group, there was no difference of
disease-free and overall survival according to the type of
procedure (PD vs. segmental BD resection, P = 0.808). In
the MID group, disease-free and overall survival was not
different between PD (n = 5) and segmental BD resection
(n = 15) (P = 0.323, Fig. 5).
Prognostic factor of extrahepatic cholangiocarcinoma
An univariate analysis showed that tumor location, gross
tumor appearance, differentiation, lymph node metasta-
sis, lymphovascular invasion, and perineural invasion
were significant prognostic factors for disease-free and
overall survival. The results of the multivariate analysis
showed that tumor involving extrapancreatic BD and
lymph node metastasis were independently poor
prognostic factors for disease-free and overall sur-
vival. (Table 2).
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Discussion
In the present study, patients with extrahepatic cholan-
giocarcinoma confined to the intrapancreatic portion of
BD (DISTAL group) had better survival than those
tumors involving the extrapancreatic BD (MID and DIF-
FUSE group) and it was independent prognostic factor.
In the MID/DIFFUSE group, perineural invasion was
significantly more frequent. The perineural space is be-
lieved to be a separate channel from the lymphatic sys-
tem, and it can act as a route for tumor metastasis [17].
Clinically, several studies showed that, in patients with
biliary tract cancer, including extrahepatic and intrahe-
patic cholangiocarcionoma and GB cancer, perineural in-
vasion is a significantly poor prognostic factor [18–20].
Table 1 Perioperative and histopathological characteristics between three groups
DISTAL (n = 32) MID (n = 20) DIFFUSE (n = 38) P value
Age (years) 65.1 ± 9.7 64.3 ± 9.6 67.1 ± 6.7 0.545
Gender (male/female) 18/14 13/7 21/17 0.757
Preoperative peak TB (mg/dl) 7.0 ± 6.2 8.9 ± 9.4 6.5 ± 4.8 0.629
CA 19–9≥ 37 21 (70.0 %) 15 (62.0 %) 25 (68.6 %) 0.932
Preoperative biliary drainage (n) 25 (83.3 %) 19 (82.6 %) 32 (84.2 %) 0.713
Type of resection <0.001
Pancreaticoduodenectomy 32 (100 %) 5 (25.0 %) 38 (100 %)
Bile duct resection 0 (0 %) 15 (75.0 %) 0 (0 %)
Operative time (min) 419.0 ± 79.8 357.5 ± 106.4 421.3 ± 69.0 0.033
Transfusion (n) 6 (18.8 %) 2 (10.0 %) 5 (13.1 %) 0.524
Postoperative complication (n) 14 (43.8 %) 5 (25.0 %) 18 (47.4 %) 0.431
Grade (I,II/III,IV) 5/9 1/4 6/12
Postoperative hospital stay (days) 29.4 ± 13.3 23.2 ± 14.2 28.6 ± 13.1 0.157
Gross tumor appearance 0.915
Infiltrating type 26 (81.3 %) 16 (80.0 %) 31 (81.6 %)
Papillary/nodular type 6 (28.7 %) 4 (20.0 %) 7 (18.4 %)
Differentiation 0.295
WD 7 (21.9 %) 5 (25.0 %) 6 (15.8 %)
MD 18 (56.3 %) 6 (30.0 %) 21 (55.3 %)
PD 7 (21.9 %) 9 (45.0 %) 11 (28.9 %)
Depth of invasion 0.002a
T1 5 (15.6 %) 6 (30.0 %) 9 (23.7 %)
T2 3 (9.4 %) 9 (45.0 %) 4 (10.5 %)
T3 24 (75.0 %) 5 (25.0 %) 25 (65.8 %)
Lymph node metastases 10 (31.3 %) 11 (55.0 %) 13 (34.2 %) 0.191
Stage (AJCC 7th) 0.631
Ia/Ib 6 (18.7 %) 9 (45.0 %) 9 (23.7 %)
IIa/IIb 26 (81.6 %) 11 (55.0 %) 29 (76.3 %)
Lymphovascular invasion 22 (68.8 %) 11 (55.0 %) 29 (76.3 %) 0.249
Perineural invasion 15 (46.9 %) 16 (70.0 %) 33 (86.8 %) 0.008b
Recurrence (n) 13 (40.6 %) 13 (65.0 %) 30 (78.9 %) 0.010c
Pattern of initial recurrence 0.449
Local recurrence 4 (30.8 %) 4 (30.7 %) 11 (35.5 %)
Distant metastases 6 (46.2 %) 4 (30.7 %) 6 (17.2 %)
Both (local + distant metastases) 3 (23.1 %) 5 (38.4 %) 14 (48.3 %)
Abbreviation: TB total bilirubin, CA cancer antigen, WD well differentiation, MD moderate differentiation, PD poor differentiation
aIn comparison between T2 and T3, the rate of T2 was higher and rate of T3 was lower in the MID group than those of the DISTAL and DIFFUSE groups
bThe rate of perineural invasion was lower in the DISTAL group than that of the MID and DIFFUSE groups
cThe rate of recurrence was lower in the DISTAL group than that of the MID and DIFFUSe groups
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In tumors involving the mid BD, the tumor may infil-
trate the adjacent structures in the hepatoduodenal liga-
ment via neural pathways easily, and the rate of
perineural invasion may be more frequent. Invasion of
cancer into this area can progress to the surrounding
structures, including regional lymph nodes, Glisson’s
sheath of the liver, and para-aortic fatty tissue. However,
in tumors confined to the intrapancreatic BD, the pan-
creas or duodenum can act as a barrier of invasion to
the surrounding perineural space, and this may be re-
lated to the less frequent perineural invasion in the IPBD
group. In the present study, although perineural invasion
was a significant prognostic factor under the univariate
analysis, it was not an independent significant prognostic
factor in multivariate analysis. The survival rate between
DISTAL and MID/DIFFUSE according to the perineural
invasion was not different (Fig. 4). Therefore, perineural
invasion may be related to the location of the tumor,
and more frequent perineural invasion in the MID/DIF-
FUSE group may result in a worse prognosis than that
of the DISTAL group.
The other factor of different prognosis according to
the tumor location is the T stage. Different survival ac-
cording to the IIa (T3N0) stage between the two groups
(Fig. 3) can be explained by the different anatomic struc-
tures in the different portions of the extrahepatic BD.
Under the current staging system, even if tumors of the
distal and middle BD have the same numeric depth of
invasion, the T stage is staged differently. Whereas in
distal BD cancer, the bile duct is within the head of the
pancreas and duodenum; in mid BD cancer, adjacent or-
gans such as the gallbladder, pancreas, and duodenum
Fig. 2 Overall (a) and disease-free survival (b) in the 3 groups
Fig. 3 Comparison of the overall survival rates between the DISTAL and the MID/DIFFUSE in IIa (T3N0; a) and IIb (AnyTN1; b) stage
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are far from the BD [21, 22]. A mid BD cancer with the
extended pericholedochal soft tissue can be staged as T2
(beyond the wall), while a tumor of the same depth of
invasion can be staged as T3 in the distal BD due to in-
vasion of the pancreas. Therefore, a T2 stage of tumor in
mid BD cancer may be classified as T3 in distal BD can-
cer in spite of the same numeric depth of invasion
(Fig. 6). A few reports revealed that pancreatic and duo-
denal invasion does not significantly affect the survival if
curative resection is performed [11]. Moreover, smooth
muscle fibers in the distal BD have a tendency to form
either a continuous or an interrupted layer; whereas, the
mid portion of the BD generally has no fibers or only
scattered muscle fibers. This thicker smooth muscle
bundle of distal BD can also affect the discrepancy of
T staging in mid and distal BD cancers [21, 22]. Con-
sidering these factors, there is a possibility of T stage
underestimation in mid BD cancer compared to distal
BD cancer in the same numeric length of the depth
of invasion [21]. Therefore, the necessity of alternative
T staging has been suggested measuring the actual
depth of invasion on a millimeter scale regardless of
the adjacent organ invasion to more accurately stage
the cancer [21, 23, 24].
In the present study, lymph node positivity, one of the
significant prognostic factors [25] in a multivariate ana-
lysis, was not related to the location of the tumor.
Whereas there was no significant survival difference
between the DISTAL and MID/DIFFUSE groups in N1
patients (stage IIb), there was a significance regarding
better survival in the DISTAL group in N0 patients
(Fig. 3). Therefore, in N0 patients, impact of tumor
location and perineural invasion may be magnified in
survival.
Our study showed different survival results according
to the location of the BD using a different approach.
First, we classified extrahepatic BD cancer as DISTAL
(confined to intrapancreatic BD) and MID/DIFFUSE
(involving extrapancreatic BD). Previous studies have
classified middle BD cancer as tumors confined to the
mid BD (MID group in our study) which could be
treated with BD resection, and distal BD cancer as in-
volvement with the intrapancreatic portion of the BD or
diffuse BD cancer (DISTAL and DIFFUSE group in this
study), in which PD was necessary [9, 15]. In others,
tumors were classified by the predominant location of
the tumor without considering diffuse bile duct cancer,
Fig. 4 Comparison of the overall survival rates between the DISTAL and the MID/DIFFUSE in presence of perineural invasion (a; Absence of
perineural invasion, b; Presence of perineural invasion)
Fig. 5 Comparison of the overall survival rates in the MID/
DIFFUSE groups according to the type of operation
(PD(pancreaticoduodenectomy) vs segmental bile duct resection)
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Table 2 Univariate and multivariate analysis of prognostic factors for overall survival
Variable 5-year overall survival (Univariate analysis) Multivariate analysis
% P P RR Exp
Sex 0.901
Male (n = 52) 35.3 %
Female (n = 38) 34.3 %
Age (years) 0.738
≤60 (n = 35) 34.7 %
>60 (n = 55) 35.2 %
Location 0.004 0.039
DISTAL (n = 32) 67.6 % 1 (Reference)
MID/DIFFUSE (n = 58) 30.2 % 2.299 1.044-5.065
Type of procedure 0.298
PD/PPPD (n = 73) 31.8 %
Bile duct resection (n = 15) 26.7 %
Transfusion 0.808
No (n = 77) 32.1 %
Yes (n = 13) 26.7 %
Postoperative complication 0.551
No (n = 53) 40.5 %
Yes (n = 37) 33.7 %
Preoperative CA 19–9 0.118
<37 (n = 30) 60.4 %
≥37 (n = 60) 36.4 %
Gross tumor appearance 0.039
Papillary (n = 17) 55.0 %
Infiltrating (n = 73) 34.2 %
Differentiation 0.028
WD (n = 18) 71.8 %
MD/PD (n = 72) 34.7 %
Depth of invasion 0.104
T1 (n = 20) 68.8 %
T2 (n = 16) 42.1 %
T3 (n = 54) 34.1 %
Node metastasis 0.001 0.007
No (n = 56) 51.6 % 1 (Reference)
Yes (n = 34) 20.0 % 2.381 1.267–4.475
Lymphovascular invasion 0.050
No (n = 28) 57.2 %
Yes (n = 62) 30.2 %
Perineural invasion 0.003
No (n = 26) 68.0 %
Yes (n = 64) 33.1 %
Adjuvant CTx 0.432
No (n = 59) 39.4 %
Yes (n = 31) 37.9 %
Abbreviation: WD well differentiation, MD moderate differentiation, PD poor differentiation
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DIFFUSE in our study [5, 13]. However, our hypothesis
was that the involvement of the middle BD itself is an
important poor prognostic factor and tumors confined
to the middle BD would have similar prognoses to dif-
fuse BD cancer. Therefore, our classification and analysis
(DISTAL vs MID/DIFFUSE) may be more desirable to
show the poor prognosis of BD cancer with involvement
in the extrapancreatic BD [14]. Additionally, we included
only R0 resection in this study. Recently, Kamposioras
K, et al. reported similar results with ours that common
BD cancer involving extrapancreatic BD showed worse
prognosis than tumor confined intrapancreatic BD due
to higher frequency of R1 resection and venous resection
[14]. Most patients of this study had worse tumor char-
acteristics than present study, 74.6 % of patients had
lymph node metastasis and R1 resection was done in
71.2 %. These advanced tumor status maybe weaken im-
pact of tumor location that extent of tumor involvement
was not independent prognostic factor. Generally, R1 re-
section has been known as an independent poor prog-
nostic predictive factor [5, 9, 11, 26, 27]. Therefore,
excluding R1 patients in the present study is valuable to
show the real impact of extrapancreatic BD involvement
on prognosis. Not only excluding R0, but also less lymph
node involvement in present study may magnify impact
of tumor location. Although we did not focus on patho-
logical findings, present study clinically supports the re-
sult of Kamposioras K’s study.
In the tumor is confined to the middle BD, there have
been debates about whether segmental BD resection is
an adequate operative procedure or not [6]. A few stud-
ies have shown that similar incidence of positive surgical
margin and similar long-term results between segmental
BD resection and PD in the cancer confined to middle
BD [7, 15, 26, 28]. Our results showed that the clinical
characteristics and long-term results between MID and
DIFFUSE were not different, and the long-term results
according to the operative procedure, either BD resec-
tion or PD in these groups, were also similar (Fig. 4).
With BD resection, sufficient radical lymph node dissec-
tion of group 2 (numbers 8, 12, and 13) is possible and
enough radial margin can be obtained [28]. Although
longitundial distal margin can obtain by PPPD, extent of
radial margin is similar between PPPD and bile duct re-
section. Poor long-term results of tumors involving the
middle BD may not due to the chosen operative proced-
ure, but involvement of the middle BD itself. Therefore,
in tumors confined to the mid BD without adjacent
organ invasion, PD may have no survival benefit and
segmental BD resection can be safely performed if R0 re-
section can be accomplished.
Our study showed poor prognosis of bile duct cancer
involving extrapancreatic duct. However, this study was
retrospective study with small patients number, there-
fore, further studies with larger cases are needed to val-
idate it.
Conclusion
In conclusion, extrahepatic cholangiocarcinoma involv-
ing the middle BD have a worse prognosis than those
confined to intrapancreatic BD. In patients with tumors
confined to the middle BD, BD resection can be an alter-
native surgical procedure to PD, if R0 resection can be
accomplished.
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Fig. 6 An example of discrepancy of T stage according to the
location. Even though two separate tumors have same depth of
invasion, tumor involved middle BD cancer (A; MID/DIFFUSE group)
would be classified as T2, while tumor confined to intrapancreatic
portion of BD (B; DISTAL group) would be classified as T3 because of
pancreas invasion
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